|
Imgatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator.〔(Statement On A Nonproprietary Name Adopted By The USAN Council - Imgatuzumab ), ''American Medical Association''.〕 This drug was developed by Genentech/Roche. == References == 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Imgatuzumab」の詳細全文を読む スポンサード リンク
|